Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768676 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating the Effects of Avanafil on Semen Parameters
A Phase 4 study, sponsored by VIVUS.
- Completed
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
NCT01768676 is a Phase 4 study that has completed, run by VIVUS. The registered enrollment target is 181 participants.
The verdict
NCT01768676, a Phase 4 study, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
Interventions
- DRUG Placebo
- DRUG avanafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01768676
The ClinicalTrials.gov registry entry for NCT01768676 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01768676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01768676 about?
NCT01768676 is a clinical study titled "Study Evaluating the Effects of Avanafil on Semen Parameters". The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
What is the current status of trial NCT01768676?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2012-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01768676?
The interventions under investigation include: Placebo (DRUG), avanafil (DRUG).
Who is sponsoring clinical trial NCT01768676?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.